Skip to main content
. 2001 Nov;8(6):1196–1203. doi: 10.1128/CDLI.8.6.1196-1203.2001

FIG. 2.

FIG. 2

Range of percent uPAR+ monocytes in patients with RRMS (not participating in the trial) (●), patients with SPMS (○), and healthy controls (□). Values are expressed as means ± SDs calculated over the study period. Patients were not currently experiencing an exacerbation.